To compare gene loci considering a phylogenetic framework is a promising approach 11 to uncover the genetic basis of human diseases. Imbalance of dopaminergic systems is suspected 12 to underlie some emerging neurological disorders. The physiological functions of dopamine are 13 transduced via G-protein-coupled receptors, including DRD5 which displays a relatively higher 14 affinity towards dopamine. Importantly, DRD5 knockout mice are hypertense, a condition 15 emerging from an increase in sympathetic tone. We investigated the evolution of DRD5, a high 16 affinity receptor for dopamine, in mammals. Surprisingly, among 124 investigated mammalian 17 genomes, we found that Cetacea lineages (Mysticeti and Odontoceti) have independently lost this 18 gene, as well as the burrowing Chrysochloris asiatica (Cape golden mole). We suggest that DRD5 19 inactivation parallels hypoxia-induced adaptations, such as peripheral vasoconstriction required 20 for deep-diving in Cetacea, in accordance with the convergent evolution of vasoconstrictor genes 21 in hypoxia-exposed animals. Our findings indicate that Cetacea are natural knockouts for DRD5 22 and might offer valuable insights into the mechanisms of some forms of vasoconstriction 23 responses and hypertension in humans.
Introduction

26
Dopamine is a neurotransmitter essential for brain function, regulating various physiological 27 processes including locomotion, cognition, and neuroendocrine functions [1, 2] . Dopamine 28 molecular actions are transduced via a specific group of G-protein coupled receptors entailing 29 two major classes: DRD1-like and DRD2-like receptors [3, 4] . While DRD1-like receptors 30 stimulate cAMP production postsynaptically, DRD2-like receptors inhibit cAMP production both 31 pre and postsynaptically [3] . The genomic structure of the underlying genes is also distinct, with 32 DRD1-like receptors yielding single exon coding regions [3] . DRD1-2 receptor classes have 33 diversified in vertebrate evolution most likely as a result of genome duplications [4] . Interestingly, 34 agonist and antagonist amino acid site conservation suggests evolutionary stasis of dopaminergic 35 pathways [4] . Among DRD1-like receptors, the DRD5 subtype displays distinctive features, 36 namely a relatively higher affinity towards dopamine, a putative agonist-independent activity and 37 low level, yet widespread, brain expression [3, [5] [6] [7] . Nonetheless, the DRD5 seems to display 38 distinct regional and cellular distribution patterns in the brain, when compared to the DRD1 and 39 DRD2 subtypes, with protein enrichment detected in the cerebral cortex, hippocampus and basal 40 ganglia [7, 8] . Peripheral expression has also been found in the adrenals [9] , kidney [10] and 41 gastrointestinal tract [11] . Despite the association with schizophrenia [12], attention-42 deficit/hyperactive disorder [13] and substance abuse [14] , gene targeting studies revealed that 43 DRD5 knock-out mice develop hypertension, showing increased blood pressure from 3 months of 44 age [2] . This hypertensive phenotype appears to result from a central nervous system defect, 45 leading to an increase in sympathetic tone and, consequently, vasoconstriction [2] . Besides 46 neuronal impairment, DRD5 disruption was also suggested to counter-regulate and modulate the 47 expression of the prohypertensive Angiotensin II Type 1 Receptor (AT1R), involved in renal salt 48 balance, blood pressure and vasoconstriction [15] [16] [17] . 49 2 Whole genome sequencing has greatly expanded our capacity to comprehend evolutionary 50 history, the role of adaptation or the basis for phenotype differences across the tree of life. Multi-51 genome comparisons have also been powerful to recognize the molecular basis of human diseases, 52 a field named as phylomedicine [18] [19] [20] [21] . Here we investigate the evolution of DRD5 in 53 mammalian species. By analysis 124 genomes covering 16 orders, we show that independent 54 coding debilitating mutations occurred in the ancestors of Mysticeti and Odontoceti (Cetacea).
55
Our findings suggest that these species are natural KOs for this dopamine receptor and might 56 offer valuable insights into the mechanisms of some forms of essential hypertension.
58
Results
59
To examine the annotation tags and distribution of the DRD5 gene across mammals, 119 60 annotated mammalian genomes available at NCBI (National Center of Biotechnology 61 Information), were scrutinized for the presence of DRD5 gene annotation and each respective 62 protein product description screened for the 'low-quality protein' (LQ) tag. This examination 63 resulted in 10 species presenting DRD5 annotation tagged as 'low-quality protein' producing gene, 
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The observed gene loss distribution, and predicted phenotypic outcome, is consistent with 202 the peripheral vasoconstriction mechanism described in Cetacea, suggested to counterbalance 203 deep-diving induced hypoxia [34, 35] . In fact, Cetacea have developed a number of physiological 204 adaptations to offset hypoxia: notably, increased blood volume and oxygen-transport protein 205 levels (hemoglobin, neuroglobin and myoglobin), allowing oxygen stores in blood, muscle 206 tissues, and brain, reduced heart rate or bradycardia, apnea and peripheral vasoconstriction [34-207 36] . Peripheral vasoconstriction allows the regional compartmentalization of blood supplies, 
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Collected genomic sequences were further imported into Geneious Prime 2019 282 (www.geneious.com) and the DRD5 gene coding sequences were manually annotated for each 283 species. Briefly, using the built-in map to reference tool with the highest sensibility parameter 284 selected, the reference single-exon DRD5 gene, 3' and 5' UTR flanked, was mapped against the 285 corresponding genomic sequence of the in-study species and aligned regions carefully screened 286 for ORF abolishing mutations including frameshift mutations and premature stop codons. For 287 Cetacea and H. amphibius DRD5 gene annotation, B. taurus DRD5 was selected as reference.
288
Regarding non-cetacean mammals DRD5 annotation, different references were chosen according 289 to the phylogenetic relationships between reference and test species ( Supplementary Table 2 ).
290
The identified mutations were next validated using the sequencing run raw data (sequencing 291 reads) retrieved from at least two independents genomic NCBI SRA projects (when available). 
